Clinical Trials
2 trialsNCT02253992 2020-10-05
An Investigational Immuno-therapy Study to Determine the Safety of Urelumab Given in Combination With Nivolumab in Solid Tumors and B-cell Non-Hodgkin's Lymphoma
Bristol-Myers Squibb
Phase 1/2 Terminated
NCT00309023 2015-10-12
Study of BMS-663513 in Patients With Advanced Cancer
Bristol-Myers Squibb
Phase 1/2 Terminated